Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Lung Cancer

  Free Subscription


Articles published in Clin Lung Cancer

Retrieve available abstracts of 202 articles:
HTML format
Text format



Single Articles


    November 2018
  1. ROSSI S, Toschi L, Finocchiaro G, Di Noia V, et al
    Impact of Exon 19 Deletion Subtypes in EGFR-Mutant Metastatic Non-Small-Cell Lung Cancer Treated With First-Line Tyrosine Kinase Inhibitors.
    Clin Lung Cancer. 2018 Nov 2. pii: S1525-7304(18)30293.
    PubMed     Text format     Abstract available


  2. PATEL JD, Paz-Ares L, Zinner RG, Barlesi F, et al
    Pemetrexed Continuation Maintenance Phase 3 Trials in Nonsquamous, Non-Small-Cell Lung Cancer: Focus on 2-Year Overall Survival and Continuum of Care.
    Clin Lung Cancer. 2018;19:e823-e830.
    PubMed     Text format     Abstract available


  3. XIE H, Wang H, Xu L, Li M, et al
    Gefitinib Versus Adjuvant Chemotherapy in Patients With Stage II-IIIA Non-Small-Cell Lung Cancer Harboring Positive EGFR Mutations: A Single-Center Retrospective Study.
    Clin Lung Cancer. 2018;19:484-492.
    PubMed     Text format     Abstract available


  4. SCHLEI Z, Tan W, Faber MG, Chen H, et al
    Safety of Same-Day Vitamin B12 Supplementation in Patients Receiving Pemetrexed for the Treatment of Non-Small-Cell Lung Cancer or Pleural Mesothelioma: A Retrospective Analysis.
    Clin Lung Cancer. 2018;19:467-475.
    PubMed     Text format     Abstract available


  5. NINOMIYA T, Ishikawa N, Inoue K, Kubo T, et al
    Phase 2 Study of Afatinib Alone or Combined With Bevacizumab in Chemonaive Patients With Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations: AfaBev-CS Study Protocol.
    Clin Lung Cancer. 2018 Nov 1. pii: S1525-7304(18)30292.
    PubMed     Text format     Abstract available


    October 2018
  6. MA K, Zhan C, Wang S, Shi Y, et al
    Spread Through Air Spaces (STAS): A New Pathologic Morphology in Lung Cancer.
    Clin Lung Cancer. 2018 Oct 26. pii: S1525-7304(18)30268.
    PubMed     Text format     Abstract available


  7. MYALL NJ, Henry S, Wood D, Neal JW, et al
    Natural Disease History, Outcomes, and Co-mutations in a Series of Patients With BRAF-Mutated Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2018 Oct 23. pii: S1525-7304(18)30264.
    PubMed     Text format     Abstract available


  8. SEYMOUR L, Le Teuff G, Brambilla E, Shepherd FA, et al
    LACE-Bio: Validation of Predictive and/or Prognostic Immunohistochemistry/Histochemistry-based Biomarkers in Resected Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2018 Oct 11. pii: S1525-7304(18)30262.
    PubMed     Text format     Abstract available


  9. KIM EK, Kim KA, Lee CY, Kim S, et al
    Molecular Diagnostic Assays and Clinicopathologic Implications of MET Exon 14 Skipping Mutation in Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2018 Oct 11. pii: S1525-7304(18)30265.
    PubMed     Text format     Abstract available


  10. GRANGEON M, Tomasini P, Chaleat S, Jeanson A, et al
    Association Between Immune-related Adverse Events and Efficacy of Immune Checkpoint Inhibitors in Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2018 Oct 11. pii: S1525-7304(18)30263.
    PubMed     Text format     Abstract available


    September 2018
  11. CHAE YK, Davis AA, Raparia K, Agte S, et al
    Association of Tumor Mutational Burden With DNA Repair Mutations and Response to Anti-PD-1/PD-L1 Therapy in Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2018 Sep 25. pii: S1525-7304(18)30253.
    PubMed     Text format     Abstract available


  12. PIRKER R, Filipits M
    Adjuvant Therapy in Patients With Completely Resected Non-small-cell Lung Cancer: Current Status and Perspectives.
    Clin Lung Cancer. 2018 Sep 24. pii: S1525-7304(18)30261.
    PubMed     Text format     Abstract available


  13. ELAMIN YY, Gomez DR, Antonoff MB, Robichaux JP, et al
    Local Consolidation Therapy (LCT) After First Line Tyrosine Kinase Inhibitor (TKI) for Patients With EGFR Mutant Metastatic Non-small-cell Lung Cancer (NSCLC).
    Clin Lung Cancer. 2018 Sep 24. pii: S1525-7304(18)30260.
    PubMed     Text format     Abstract available


  14. MENG X, Gao Y, Yang L, Jing H, et al
    Immune Microenvironment Differences Between Squamous and Non-squamous Non-small-cell Lung Cancer and Their Influence on the Prognosis.
    Clin Lung Cancer. 2018 Sep 24. pii: S1525-7304(18)30257.
    PubMed     Text format     Abstract available


  15. RICE SR, Molitoris JK, Vyfhuis MAL, Edelman MJ, et al
    Lymph Node Size Predicts for Asymptomatic Brain Metastases in Patients With Non-small-cell Lung Cancer at Diagnosis.
    Clin Lung Cancer. 2018 Sep 24. pii: S1525-7304(18)30259.
    PubMed     Text format     Abstract available


  16. KSIENSKI D, Wai ES, Croteau N, Fiorino L, et al
    Efficacy of Nivolumab and Pembrolizumab in Patients With Advanced Non-Small-Cell Lung Cancer Needing Treatment Interruption Because of Adverse Events: A Retrospective Multicenter Analysis.
    Clin Lung Cancer. 2018 Sep 22. pii: S1525-7304(18)30250.
    PubMed     Text format     Abstract available


  17. ZHU VW, Lu Y, Ignatius Ou SH
    Severe Acute Hepatitis in a Patient Receiving Alectinib for ALK-Positive Non-Small-Cell Lung Cancer: Histologic Analysis.
    Clin Lung Cancer. 2018 Sep 21. pii: S1525-7304(18)30251.
    PubMed     Text format    


  18. SCHONEWOLF CA, Heskel M, Doucette A, Singhal S, et al
    Five-year Long-term Outcomes of Stereotactic Body Radiation Therapy for Operable Versus Medically Inoperable Stage I Non-small-cell Lung Cancer: Analysis by Operability, Fractionation Regimen, Tumor Size, and Tumor Location.
    Clin Lung Cancer. 2018 Sep 20. pii: S1525-7304(18)30237.
    PubMed     Text format     Abstract available


  19. MILLER CJ, Martin B, Stang K, Hutten R, et al
    Predictors of Distant Failure After Stereotactic Body Radiation Therapy for Stages I to IIA Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2018 Sep 8. pii: S1525-7304(18)30235.
    PubMed     Text format     Abstract available


  20. NG TL, Yu H, Smith DE, Boyle TA, et al
    Preselection of Lung Cancer Cases Using FGFR1 mRNA and Gene Copy Number for Treatment With Ponatinib.
    Clin Lung Cancer. 2018 Sep 7. pii: S1525-7304(18)30234.
    PubMed     Text format     Abstract available


  21. BERRY MF, Canchola AJ, Gensheimer MF, Gomez SL, et al
    Factors Associated With Treatment of Clinical Stage I Non-Small-cell Lung Cancer: A Population-based Analysis.
    Clin Lung Cancer. 2018;19:e745-e758.
    PubMed     Text format     Abstract available


  22. REN S, Rivard CJ, Yu H, Genova C, et al
    A miRNA Panel Predicts Sensitivity of FGFR Inhibitor in Lung Cancer Cell Lines.
    Clin Lung Cancer. 2018;19:450-456.
    PubMed     Text format     Abstract available


    August 2018
  23. AKAMATSU H, Harada H, Tokunaga S, Yoshimura N, et al
    A Phase II Study of Gefitinib With Concurrent Thoracic Radiotherapy in Patients With Unresectable, Stage III Non-small-cell Lung Cancer Harboring EGFR Mutations (WJOG6911L).
    Clin Lung Cancer. 2018 Aug 30. pii: S1525-7304(18)30230.
    PubMed     Text format     Abstract available


  24. KIM E, Wu HG, Keam B, Kim TM, et al
    Significance of (18)F-FDG PET Parameters According to Histologic Subtype in the Treatment Outcome of Stage III Non-small-cell Lung Cancer Undergoing Definitive Concurrent Chemoradiotherapy.
    Clin Lung Cancer. 2018 Aug 30. pii: S1525-7304(18)30231.
    PubMed     Text format     Abstract available


  25. GRASS GD, Naghavi AO, Abuodeh YA, Perez BA, et al
    Analysis of Relapse Events After Definitive Chemoradiotherapy in Locally Advanced Non-Small-Cell Lung Cancer Patients.
    Clin Lung Cancer. 2018 Aug 29. pii: S1525-7304(18)30203.
    PubMed     Text format     Abstract available


  26. WU F, Lin X, Yang Z, Sun Z, et al
    Phase III Randomized Trial of Palonosetron and Dexamethasone With or Without Aprepitant to Prevent Nausea and Vomiting Induced by Full-dose Single-day Cisplatin-based Chemotherapy in Lung Cancer.
    Clin Lung Cancer. 2018 Aug 23. pii: S1525-7304(18)30200.
    PubMed     Text format     Abstract available


  27. ZHAO X, Feng Z, Wang G, Pang H, et al
    Ceritinib Alone for Crizotinib-naive Versus Crizotinib-pretreated for Management of Anaplastic Lymphoma Kinase-rearrangement Non-Small-cell Lung Cancer: A Systematic Review.
    Clin Lung Cancer. 2018 Aug 23. pii: S1525-7304(18)30207.
    PubMed     Text format     Abstract available


  28. YU TM, Morrison C, Gold EJ, Tradonsky A, et al
    Multiple Biomarker Testing Tissue Consumption and Completion Rates With Single-gene Tests and Investigational Use of Oncomine Dx Target Test for Advanced Non-Small-cell Lung Cancer: A Single-center Analysis.
    Clin Lung Cancer. 2018 Aug 23. pii: S1525-7304(18)30204.
    PubMed     Text format     Abstract available


  29. WAINER Z, Wright GM, Gough K, Daniels MG, et al
    Sex-Dependent Staging in Non-Small-Cell Lung Cancer; Analysis of the Effect of Sex Differences in the Eighth Edition of the Tumor, Node, Metastases Staging System.
    Clin Lung Cancer. 2018 Aug 22. pii: S1525-7304(18)30198.
    PubMed     Text format     Abstract available


  30. SUZUKI R, Wei X, Allen PK, Welsh JW, et al
    Twice-daily Thoracic Radiotherapy for Limited-stage Small-cell Lung Cancer Does Not Increase the Incidence of Acute Severe Esophagitis.
    Clin Lung Cancer. 2018 Aug 22. pii: S1525-7304(18)30206.
    PubMed     Text format     Abstract available


  31. IAMS WT, Yu H, Shyr Y, Patil T, et al
    First-line Chemotherapy Responsiveness and Patterns of Metastatic Spread Identify Clinical Syndromes Present Within Advanced KRAS Mutant Non-Small-cell Lung Cancer With Different Prognostic Significance.
    Clin Lung Cancer. 2018 Aug 22. pii: S1525-7304(18)30205.
    PubMed     Text format     Abstract available


  32. OWEN DH, Wei L, Bertino EM, Edd T, et al
    Incidence, Risk Factors, and Effect on Survival of Immune-related Adverse Events in Patients With Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2018 Aug 22. pii: S1525-7304(18)30202.
    PubMed     Text format     Abstract available


  33. FARRELL MJ, Yahya JB, Degnin C, Chen Y, et al
    Radiation Dose and Fractionation for Limited-stage Small-cell Lung Cancer: Survey of US Radiation Oncologists on Practice Patterns.
    Clin Lung Cancer. 2018 Aug 22. pii: S1525-7304(18)30209.
    PubMed     Text format     Abstract available


  34. RENAUD S, Guerrera F, Seitlinger J, Reeb J, et al
    KRAS-specific Amino Acid Substitutions are Associated With Different Responses to Chemotherapy in Advanced Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2018 Aug 22. pii: S1525-7304(18)30199.
    PubMed     Text format     Abstract available


  35. HATA A, Katakami N, Shimokawa M, Mitsudomi T, et al
    Docetaxel Plus RAmucirumab With Primary Prophylactic Pegylated Granulocyte-ColONy Stimulating Factor Support for Elderly Patients With Advanced Non-small-cell Lung Cancer: A Multicenter Prospective Single Arm Phase II Trial: DRAGON Study (WJOG9416L).
    Clin Lung Cancer. 2018 Aug 7. pii: S1525-7304(18)30193.
    PubMed     Text format     Abstract available


  36. BARBIE DA, Spira A, Kelly K, Humeniuk R, et al
    Phase 1B Study of Momelotinib Combined With Trametinib in Metastatic, Kirsten Rat Sarcoma Viral Oncogene Homolog-Mutated Non-Small-Cell Lung Cancer After Platinum-Based Chemotherapy Treatment Failure.
    Clin Lung Cancer. 2018 Aug 4. pii: S1525-7304(18)30171.
    PubMed     Text format     Abstract available


    July 2018
  37. CUMMINGS MA, Ma SJ, Hermann G, Serra L, et al
    Comparison of Single- and Five-fraction Regimens of Stereotactic Body Radiation Therapy for Peripheral Early-stage Non-small-cell Lung Cancer: A Two-institution Propensity-matched Analysis.
    Clin Lung Cancer. 2018 Jul 30. pii: S1525-7304(18)30190.
    PubMed     Text format     Abstract available


  38. IIJIMA Y, Hirotsu Y, Mochizuki H, Amemiya K, et al
    Dynamic Changes and Drug-Induced Selection of Resistant Clones in a Patient With EGFR-Mutated Adenocarcinoma That Acquired T790M Mutation and Transformed to Small-Cell Lung Cancer.
    Clin Lung Cancer. 2018 Jul 26. pii: S1525-7304(18)30169.
    PubMed     Text format    


  39. VERMA V, Schonewolf CA, Cushman TR, Post CM, et al
    Impact of Enlarged Nonhypermetabolic Lymph Nodes on Outcomes After Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2018 Jul 25. pii: S1525-7304(18)30172.
    PubMed     Text format     Abstract available


  40. DRIESSEN EJM, Janssen-Heijnen MLG, Maas HA, Dingemans AC, et al
    Study Protocol of the NVALT25-ELDAPT Trial: Selecting the Optimal Treatment for Older Patients With Stage III Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2018 Jul 9. pii: S1525-7304(18)30170.
    PubMed     Text format     Abstract available


    June 2018
  41. CHANG H, Yang Y, Lee JS, Jheon SH, et al
    Epidermal Growth Factor Receptor Gene Amplification Predicts Worse Outcome in Patients With Surgically Resected Nonadenocarcinoma Lung Cancer.
    Clin Lung Cancer. 2018 Jun 27. pii: S1525-7304(18)30162.
    PubMed     Text format     Abstract available


  42. WU F, Zhang S, Xiong A, Gao G, et al
    A Phase II Clinical Trial of Apatinib in Pretreated Advanced Non-squamous Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2018 Jun 27. pii: S1525-7304(18)30161.
    PubMed     Text format     Abstract available


  43. RAGHAVAN G, Shaverdian N, Chan S, Chu FI, et al
    Comparing Outcomes of Patients With Early-Stage Non-Small-Cell Lung Cancer Treated With Stereotactic Body Radiotherapy Based on Frailty Status.
    Clin Lung Cancer. 2018 Jun 6. pii: S1525-7304(18)30128.
    PubMed     Text format     Abstract available


  44. ARUNACHALAM A, Li H, Bittoni MA, Camacho R, et al
    Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With Second-Line Therapies for Medicare Patients With Advanced Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2018 Jun 6. pii: S1525-7304(18)30136.
    PubMed     Text format     Abstract available


  45. LEE A, Howell VM, Itchins M, Wheeler HR, et al
    ROS1-Rearranged Non-Small-Cell Lung Cancer, Factor V Leiden, and Recurrent Venous Thromboses.
    Clin Lung Cancer. 2018 Jun 5. pii: S1525-7304(18)30135.
    PubMed     Text format    


  46. SU CT, Bhargava A, Shah CD, Halmos B, et al
    Screening Patterns and Mortality Differences in Patients With Lung Cancer at an Urban Underserved Community.
    Clin Lung Cancer. 2018 Jun 5. pii: S1525-7304(18)30139.
    PubMed     Text format     Abstract available


    May 2018
  47. PAOLINI D, Tiseo M, Demma F, Furneri G, et al
    Ventana ALK (D5F3) in the Detection of Patients Affected by Anaplastic Lymphoma Kinase-positive Non-Small-cell Lung Cancer: Clinical and Budget Effect.
    Clin Lung Cancer. 2018 May 31. pii: S1525-7304(18)30132.
    PubMed     Text format     Abstract available


  48. BORDONI R, Ciardiello F, von Pawel J, Cortinovis D, et al
    Patient-Reported Outcomes in OAK: A Phase III Study of Atezolizumab Versus Docetaxel in Advanced Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2018 May 31. pii: S1525-7304(18)30131.
    PubMed     Text format     Abstract available


  49. KAWACHI H, Fujimoto D, Morimoto T, Ito M, et al
    Clinical Characteristics and Prognosis of Patients With Advanced Non-Small-cell Lung Cancer Who Are Ineligible for Clinical Trials.
    Clin Lung Cancer. 2018 May 26. pii: S1525-7304(18)30134.
    PubMed     Text format     Abstract available


  50. KOGURE Y, Saka H, Takiguchi Y, Atagi S, et al
    A Randomized Phase III Study Comparing Carboplatin With Nab-Paclitaxel Versus Docetaxel for Elderly Patients With Squamous-Cell Lung Cancer: Study Protocol.
    Clin Lung Cancer. 2018 May 19. pii: S1525-7304(18)30110.
    PubMed     Text format     Abstract available


  51. RAMAN S, Bissonnette JP, Warner A, Le L, et al
    Rationale and Protocol for a Canadian Multicenter Phase II Randomized Trial Assessing Selective Metabolically Adaptive Radiation Dose Escalation in Locally Advanced Non-small-cell Lung Cancer (NCT02788461).
    Clin Lung Cancer. 2018 May 16. pii: S1525-7304(18)30107.
    PubMed     Text format     Abstract available


  52. RODRIGUEZ DE DIOS N, Counago F, Lopez JL, Calvo P, et al
    Treatment Design and Rationale for a Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for SCLC: PREMER Trial on Behalf of the Oncologic Group for the Study of Lung Cancer/Spanish Radiation Oncology Group-Radia
    Clin Lung Cancer. 2018 May 10. pii: S1525-7304(18)30108.
    PubMed     Text format     Abstract available


  53. SAIKI M, Kitazono S, Yoshizawa T, Dotsu Y, et al
    Characterization of Computed Tomography Imaging of Rearranged During Transfection-rearranged Lung Cancer.
    Clin Lung Cancer. 2018 May 10. pii: S1525-7304(18)30088.
    PubMed     Text format     Abstract available


  54. ZER A, Sung MR, Walia P, Khoja L, et al
    Correlation of Neutrophil to Lymphocyte Ratio and Absolute Neutrophil Count With Outcomes With PD-1 Axis Inhibitors in Patients With Advanced Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2018 May 8. pii: S1525-7304(18)30090.
    PubMed     Text format     Abstract available


  55. LOONG HH, Raymond VM, Shiotsu Y, Chua DTT, et al
    Clinical Application of Genomic Profiling With Circulating Tumor DNA for Management of Advanced Non-Small-cell Lung Cancer in Asia.
    Clin Lung Cancer. 2018 May 7. pii: S1525-7304(18)30104.
    PubMed     Text format     Abstract available


  56. BITTONI MA, Arunachalam A, Li H, Camacho R, et al
    Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With First-line Therapies for Medicare Patients 65 Years and Older With Advanced Non-small-cell Lung Cancer: A Retrospective Study.
    Clin Lung Cancer. 2018 May 7. pii: S1525-7304(18)30099.
    PubMed     Text format     Abstract available


  57. HIRSH V, Wan Y, Lin FJ, Margunato-Debay S, et al
    Quality-adjusted Outcomes Stratified by Response in Patients With Advanced Non-Small-cell Lung Cancer Receiving First-line nab-Paclitaxel/Carboplatin or Paclitaxel/Carboplatin.
    Clin Lung Cancer. 2018 May 7. pii: S1525-7304(18)30105.
    PubMed     Text format     Abstract available


  58. FUJIMOTO D, Sato Y, Morimoto T, Uehara K, et al
    Programmed Cell Death Ligand 1 Expression in Non-Small-cell Lung Cancer Patients With Interstitial Lung Disease: A Matched Case-control Study.
    Clin Lung Cancer. 2018 May 5. pii: S1525-7304(18)30094.
    PubMed     Text format     Abstract available


  59. FUKUI T, Okuma Y, Nakahara Y, Otani S, et al
    Activity of Nivolumab and Utility of Neutrophil-to-Lymphocyte Ratio as a Predictive Biomarker for Advanced Non-Small-Cell Lung Cancer: A Prospective Observational Study.
    Clin Lung Cancer. 2018 May 5. pii: S1525-7304(18)30103.
    PubMed     Text format     Abstract available


  60. GINESTET F, Lambros L, Le Flahec G, Marcorelles P, et al
    Evaluation of a Dual ALK/ROS1 Fluorescent In Situ Hybridization Test in Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2018 May 5. pii: S1525-7304(18)30098.
    PubMed     Text format     Abstract available


  61. FACCHINETTI F, Gnetti L, Caruana P, Fornaroli F, et al
    Widespread Nivolumab-induced Enteropathy in a Long Responder Non-Small-cell Lung Cancer Patient.
    Clin Lung Cancer. 2018 May 5. pii: S1525-7304(18)30095.
    PubMed     Text format    


  62. LAMBROS L, Uguen A
    Toward a Molecular Diagnosis in a Single Day for Patients With Advanced Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2018 May 5. pii: S1525-7304(18)30044.
    PubMed     Text format    


  63. OKUMA Y, Wakui H, Utsumi H, Sagawa Y, et al
    Soluble Programmed Cell Death Ligand 1 as a Novel Biomarker for Nivolumab Therapy for Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2018 May 5. pii: S1525-7304(18)30096.
    PubMed     Text format     Abstract available


  64. FARRELL MJ, Yahya JB, Degnin C, Chen Y, et al
    Timing of Thoracic Radiation Therapy With Chemotherapy in Limited-stage Small-cell Lung Cancer: Survey of US Radiation Oncologists on Current Practice Patterns.
    Clin Lung Cancer. 2018 May 5. pii: S1525-7304(18)30089.
    PubMed     Text format     Abstract available


  65. ATAGI S, Mizusawa J, Ishikura S, Takahashi T, et al
    Chemoradiotherapy in Elderly Patients With Non-Small-Cell Lung Cancer: Long-Term Follow-Up of a Randomized Trial (JCOG0301).
    Clin Lung Cancer. 2018 May 5. pii: S1525-7304(18)30100.
    PubMed     Text format     Abstract available


  66. VANDERLAAN PA, Chen Y, DiStasio M, Rangachari D, et al
    Molecular Testing Turnaround Time in Non-Small-Cell Lung Cancer: Monitoring a Moving Target.
    Clin Lung Cancer. 2018 May 4. pii: S1525-7304(18)30087.
    PubMed     Text format    


    April 2018
  67. CHIN AL, Kumar KA, Guo HH, Maxim PG, et al
    Prognostic Value of Pretreatment FDG-PET Parameters in High-dose Image-guided Radiotherapy for Oligometastatic Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2018 Apr 19. pii: S1525-7304(18)30085.
    PubMed     Text format     Abstract available


  68. GIULIANI M, Mathew AS, Bahig H, Bratman SV, et al
    SUNSET: Stereotactic Radiation for Ultracentral Non-Small-Cell Lung Cancer-A Safety and Efficacy Trial.
    Clin Lung Cancer. 2018 Apr 18. pii: S1525-7304(18)30073.
    PubMed     Text format     Abstract available


    March 2018
  69. PAXIMADIS P, Beebe-Dimmer JL, George J, Schwartz AG, et al
    Comparing Treatment Strategies for Stage I Small-cell lung Cancer.
    Clin Lung Cancer. 2018 Mar 23. pii: S1525-7304(18)30059.
    PubMed     Text format     Abstract available


  70. GIACCONE G, Sanborn RE, Waqar SN, Martinez-Marti A, et al
    A Placebo-Controlled Phase II Study of Ruxolitinib in Combination With Pemetrexed and Cisplatin for First-Line Treatment of Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer and Systemic Inflammation.
    Clin Lung Cancer. 2018 Mar 23. pii: S1525-7304(18)30058.
    PubMed     Text format     Abstract available


  71. HIRSCH FR, Kerr KM, Bunn PA Jr, Kim ES, et al
    Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies.
    Clin Lung Cancer. 2018 Mar 21. pii: S1525-7304(18)30056.
    PubMed     Text format     Abstract available


  72. WU YL, Sequist LV, Tan EH, Geater SL, et al
    Afatinib as First-line Treatment of Older Patients With EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Subgroup Analyses of the LUX-Lung 3, LUX-Lung 6, and LUX-Lung 7 Trials.
    Clin Lung Cancer. 2018 Mar 17. pii: S1525-7304(18)30051.
    PubMed     Text format     Abstract available


  73. REIS H, Metzenmacher M, Goetz M, Savvidou N, et al
    MET Expression in Advanced Non-Small-Cell Lung Cancer: Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy.
    Clin Lung Cancer. 2018 Mar 17. pii: S1525-7304(18)30052.
    PubMed     Text format     Abstract available


  74. GRILLEY-OLSON JE, Weiss J, Ivanova A, Villaruz LC, et al
    Phase Ib Study of Bavituximab With Carboplatin and Pemetrexed in Chemotherapy-Naive Advanced Nonsquamous Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2018 Mar 17. pii: S1525-7304(18)30050.
    PubMed     Text format     Abstract available


  75. TOH CK, Ong WS, Lim WT, Tan DS, et al
    A Decade of Never-smokers Among Lung Cancer Patients-Increasing Trend and Improved Survival.
    Clin Lung Cancer. 2018 Mar 17. pii: S1525-7304(18)30055.
    PubMed     Text format     Abstract available


  76. KIM CR, Kim B, Ning MS, Reddy JP, et al
    Cost Analysis of PET/CT Versus CT as Surveillance for Stage III Non-Small-Cell Lung Cancer After Definitive Radiation Therapy.
    Clin Lung Cancer. 2018 Mar 17. pii: S1525-7304(18)30054.
    PubMed     Text format     Abstract available


  77. VISSER S, de Mol M, Cheung K, van Toor JJ, et al
    Treatment Satisfaction of Patients With Advanced Non-Small-cell Lung Cancer Receiving Platinum-based Chemotherapy: Results From a Prospective Cohort Study (PERSONAL).
    Clin Lung Cancer. 2018 Mar 17. pii: S1525-7304(18)30045.
    PubMed     Text format     Abstract available


  78. DEEK MP, Kim S, Beck R, Yegya-Raman N, et al
    Variations in Initiation Dates of Chemotherapy and Radiation Therapy for Definitive Management of Inoperable Non-Small Cell Lung Cancer Are Associated With Decreases in Overall Survival.
    Clin Lung Cancer. 2018 Mar 17. pii: S1525-7304(18)30049.
    PubMed     Text format     Abstract available


  79. ARDESHIR-LARIJANI F, Bhateja P, Lipka MB, Sharma N, et al
    KMT2D Mutation Is Associated With Poor Prognosis in Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2018 Mar 16. pii: S1525-7304(18)30047.
    PubMed     Text format     Abstract available


  80. SIO TT, Prayongrat A, Zhang Y, Lin Q, et al
    The Road Less Traveled: Should We Omit Prophylactic Cranial Irradiation for Patients With Small Cell Lung Cancer?
    Clin Lung Cancer. 2018 Mar 16. pii: S1525-7304(18)30048.
    PubMed     Text format     Abstract available


  81. WAQAR SN, Samson PP, Robinson CG, Bradley J, et al
    Non-small-cell Lung Cancer With Brain Metastasis at Presentation.
    Clin Lung Cancer. 2018 Mar 8. pii: S1525-7304(18)30019.
    PubMed     Text format     Abstract available


    February 2018
  82. FARRELL MJ, Yahya JB, Degnin C, Chen Y, et al
    Prophylactic Cranial Irradiation for Limited-Stage Small-Cell Lung Cancer: Survey of US Radiation Oncologists on Current Practice Patterns.
    Clin Lung Cancer. 2018 Feb 23. pii: S1525-7304(18)30042.
    PubMed     Text format     Abstract available


  83. PETRELLI F, Maltese M, Tomasello G, Conti B, et al
    Clinical and Molecular Predictors of PD-L1 Expression in Non-Small-Cell Lung Cancer: Systematic Review and Meta-analysis.
    Clin Lung Cancer. 2018 Feb 21. pii: S1525-7304(18)30025.
    PubMed     Text format     Abstract available


  84. STONE CJL, Vaid HM, Selvam R, Ashworth A, et al
    Multidisciplinary Clinics in Lung Cancer Care: A Systematic Review.
    Clin Lung Cancer. 2018 Feb 21. pii: S1525-7304(18)30020.
    PubMed     Text format     Abstract available


  85. TAKASHIMA Y, Sakakibara-Konishi J, Hatanaka Y, Hatanaka KC, et al
    Clinicopathologic Features and Immune Microenvironment of Non-Small-cell Lung Cancer With Primary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
    Clin Lung Cancer. 2018 Feb 19. pii: S1525-7304(18)30023.
    PubMed     Text format     Abstract available


  86. NADLER E, Espirito JL, Pavilack M, Boyd M, et al
    Treatment Patterns and Clinical Outcomes Among Metastatic Non-Small-Cell Lung Cancer Patients Treated in the Community Practice Setting.
    Clin Lung Cancer. 2018 Feb 17. pii: S1525-7304(18)30021.
    PubMed     Text format     Abstract available


  87. WU TH, Hsiue EH, Lee JH, Lin CC, et al
    Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non-Small-cell Lung Cancer Patients.
    Clin Lung Cancer. 2018 Feb 1. pii: S1525-7304(18)30017.
    PubMed     Text format     Abstract available


  88. BILFINGER TV, Albano D, Perwaiz M, Keresztes R, et al
    Survival Outcomes Among Lung Cancer Patients Treated Using a Multidisciplinary Team Approach.
    Clin Lung Cancer. 2018 Feb 1. pii: S1525-7304(18)30018.
    PubMed     Text format     Abstract available


  89. HIDA T, Kaji R, Satouchi M, Ikeda N, et al
    Atezolizumab in Japanese Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer: A Subgroup Analysis of the Phase 3 OAK Study.
    Clin Lung Cancer. 2018 Feb 1. pii: S1525-7304(18)30016.
    PubMed     Text format     Abstract available


    January 2018
  90. KHUNGER M, Jain P, Rakshit S, Pasupuleti V, et al
    Safety and Efficacy of PD-1/PD-L1 Inhibitors in Treatment-Naive and Chemotherapy-Refractory Patients With Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.
    Clin Lung Cancer. 2018 Jan 10. pii: S1525-7304(18)30002.
    PubMed     Text format     Abstract available


  91. KOBAYASHI K, Nakachi I, Naoki K, Satomi R, et al
    Real-world Efficacy and Safety of Nivolumab for Advanced Non-Small-cell Lung Cancer: A Retrospective Multicenter Analysis.
    Clin Lung Cancer. 2018 Jan 5. pii: S1525-7304(18)30001.
    PubMed     Text format     Abstract available


  92. ZHENG Y, Shi A, Wang W, Yu H, et al
    Posttreatment Immune Parameters Predict Cancer Control and Pneumonitis in Stage I Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Ablative Radiotherapy.
    Clin Lung Cancer. 2018 Jan 4. pii: S1525-7304(17)30351.
    PubMed     Text format     Abstract available


  93. TAMURA T, Miyazaki K, Shiozawa T, Satoh H, et al
    Comparative Effectiveness and Resource Usage in Patients Receiving First-line Taxol-based Chemotherapy for Stage IV NSCLC.
    Clin Lung Cancer. 2018;19:e67.
    PubMed     Text format    


    December 2017
  94. GRIDELLI C, Baas P, Barlesi F, Ciardiello F, et al
    Second-Line Treatment Options in Non-Small-Cell Lung Cancer: Report From an International Experts Panel Meeting of the Italian Association of Thoracic Oncology.
    Clin Lung Cancer. 2017 Dec 22. pii: S1525-7304(17)30349.
    PubMed     Text format     Abstract available


  95. QIU T, Li W, Zhang T, Xing P, et al
    Distinct MET Protein Localization Associated With MET Exon 14 Mutation Types in Patients With Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Dec 21. pii: S1525-7304(17)30345.
    PubMed     Text format     Abstract available


  96. PARK W, Kwon D, Saravia D, Desai A, et al
    Developing a Predictive Model for Clinical Outcomes of Advanced Non-Small Cell Lung Cancer Patients Treated With Nivolumab.
    Clin Lung Cancer. 2017 Dec 21. pii: S1525-7304(17)30346.
    PubMed     Text format     Abstract available


  97. RAMALINGAM SS, Perol M, Reck M, Kowalyszyn RD, et al
    Efficacy and Safety of Ramucirumab With Docetaxel Versus Placebo With Docetaxel as Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer: A Subgroup Analysis According to Patient Age in the REVEL Trial.
    Clin Lung Cancer. 2017 Dec 21. pii: S1525-7304(17)30350.
    PubMed     Text format     Abstract available


  98. BERNHARDT D, Konig L, Aufderstrasse S, Krisam J, et al
    Generation of a New Disease-specific Prognostic Score for Patients With Brain Metastases From Small-cell Lung Cancer Treated With Whole Brain Radiotherapy (BMS-Score) and Validation of Two Other Indices.
    Clin Lung Cancer. 2017 Dec 15. pii: S1525-7304(17)30343.
    PubMed     Text format     Abstract available


  99. SHARMA S, McMillan MT, Doucette A, Cohen RB, et al
    Effect of Prophylactic Cranial Irradiation on Overall Survival in Metastatic Small-Cell Lung Cancer: A Propensity Score-Matched Analysis.
    Clin Lung Cancer. 2017 Dec 14. pii: S1525-7304(17)30342.
    PubMed     Text format     Abstract available


  100. SALEM A, Mistry H, Backen A, Hodgson C, et al
    Cell Death, Inflammation, Tumor Burden, and Proliferation Blood Biomarkers Predict Lung Cancer Radiotherapy Response and Correlate With Tumor Volume and Proliferation Imaging.
    Clin Lung Cancer. 2017 Dec 11. pii: S1525-7304(17)30341.
    PubMed     Text format     Abstract available


  101. HALD SM, Rakaee M, Martinez I, Richardsen E, et al
    LAG-3 in Non-Small-cell Lung Cancer: Expression in Primary Tumors and Metastatic Lymph Nodes Is Associated With Improved Survival.
    Clin Lung Cancer. 2017 Dec 11. pii: S1525-7304(17)30340.
    PubMed     Text format     Abstract available


  102. STOY SP, Segal JP, Mueller J, Furtado LV, et al
    Feasibility of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Cytology Specimens for Next Generation Sequencing in Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Dec 5. pii: S1525-7304(17)30322.
    PubMed     Text format     Abstract available


    November 2017
  103. MA SJ, Cummings M, Serra LM, Syed YA, et al
    Three- Versus Five-Fraction Regimens of Stereotactic Body Radiotherapy for Peripheral Early-Stage Non-Small-Cell Lung Cancer: A Two-Institution Propensity Score-Matched Analysis.
    Clin Lung Cancer. 2017 Nov 26. pii: S1525-7304(17)30319.
    PubMed     Text format     Abstract available


  104. DALWADI SM, Szeja SS, Bernicker EH, Butler EB, et al
    Practice Patterns and Outcomes in Elderly Stage I Non-Small-cell Lung Cancer: A 2004 to 2012 SEER Analysis.
    Clin Lung Cancer. 2017 Nov 21. pii: S1525-7304(17)30316.
    PubMed     Text format     Abstract available


  105. DAMHUIS RAM, Senan S, Belderbos JS
    Usage of Prophylactic Cranial Irradiation in Elderly Patients With Small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Nov 21. pii: S1525-7304(17)30317.
    PubMed     Text format     Abstract available


  106. MASSABEAU C, Khalifa J, Filleron T, Modesto A, et al
    Continuous Infusion of Cilengitide Plus Chemoradiotherapy for Patients With Stage III Non-Small-cell Lung Cancer: A Phase I Study.
    Clin Lung Cancer. 2017 Nov 21. pii: S1525-7304(17)30314.
    PubMed     Text format     Abstract available


  107. RECK M, Garon EB, Paz-Ares L, Ponce S, et al
    Randomized, Double-Blind Phase Ib/III Study of Erlotinib With Ramucirumab or Placebo in Previously Untreated EGFR-Mutant Metastatic Non-Small-Cell Lung Cancer (RELAY): Phase Ib Results.
    Clin Lung Cancer. 2017 Nov 21. pii: S1525-7304(17)30315.
    PubMed     Text format     Abstract available


  108. SURA K, Grills IS, Vu CC, Stevens CW, et al
    Improved Survival With Increased Time-To-Radiation and Sequential Chemotherapy After Surgery for pN2 Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Nov 17. pii: S1525-7304(17)30305.
    PubMed     Text format     Abstract available


  109. LEE S, Song SY, Kim SS, Choi W, et al
    Feasible Optimization of Stereotactic Ablative Radiotherapy Dose by Tumor Size for Stage I Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Nov 14. pii: S1525-7304(17)30313.
    PubMed     Text format     Abstract available


  110. JIANG T, Liu H, Qiao M, Li X, et al
    Impact of Clinicopathologic Features on the Efficacy of PD-1/PD-L1 Inhibitors in Patients With Previously Treated Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Nov 9. pii: S1525-7304(17)30312.
    PubMed     Text format     Abstract available


    October 2017
  111. NAKAMURA H, Koizumi H, Sakai H, Kimura H, et al
    Accuracy of the cobas EGFR Mutation Assay in Non-small-cell Lung Cancer Compared With Three Laboratory-developed Tests.
    Clin Lung Cancer. 2017 Oct 28. pii: S1525-7304(17)30309.
    PubMed     Text format     Abstract available


  112. GOBBINI E, Pilotto S, Pasello G, Polo V, et al
    Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung Cancer.
    Clin Lung Cancer. 2017 Oct 28. pii: S1525-7304(17)30306.
    PubMed     Text format     Abstract available


  113. ZHOU H, Zhang Y, Qiu Z, Chen G, et al
    Nomogram to Predict Cause-Specific Mortality in Patients With Surgically Resected Stage I Non-Small-Cell Lung Cancer: A Competing Risk Analysis.
    Clin Lung Cancer. 2017 Oct 28. pii: S1525-7304(17)30310.
    PubMed     Text format     Abstract available


  114. TAKADA K, Toyokawa G, Shoji F, Okamoto T, et al
    The Significance of the PD-L1 Expression in Non-Small-Cell Lung Cancer: Trenchant Double Swords as Predictive and Prognostic Markers.
    Clin Lung Cancer. 2017 Oct 28. pii: S1525-7304(17)30308.
    PubMed     Text format     Abstract available


  115. MA SJ, Serra LM, Syed YA, Hermann GM, et al
    Comparison of Single- and Three-fraction Schedules of Stereotactic Body Radiation Therapy for Peripheral Early-stage Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Oct 28. pii: S1525-7304(17)30304.
    PubMed     Text format     Abstract available


  116. JOHNSON DY, Short RG, Patz EF Jr
    Sequential CT Findings in Patients With Non-small-cell Lung Cancer Receiving Nivolumab.
    Clin Lung Cancer. 2017 Oct 28. pii: S1525-7304(17)30303.
    PubMed     Text format     Abstract available


  117. PELLEGRINO B, Facchinetti F, Bordi P, Silva M, et al
    Lung Toxicity in Non-Small-Cell Lung Cancer Patients Exposed to ALK Inhibitors: Report of a Peculiar Case and Systematic Review of the Literature.
    Clin Lung Cancer. 2017 Oct 28. pii: S1525-7304(17)30302.
    PubMed     Text format     Abstract available


  118. ITO K, Suzuki Y, Saiki H, Sakaguchi T, et al
    Utility of Liquid Biopsy by Improved PNA-LNA PCR Clamp Method for Detecting EGFR Mutation at Initial Diagnosis of Non-Small-Cell Lung Cancer: Observational Study of 190 Consecutive Cases in Clinical Practice.
    Clin Lung Cancer. 2017 Oct 28. pii: S1525-7304(17)30311.
    PubMed     Text format     Abstract available


  119. CUPP J, Culakova E, Poniewierski MS, Dale DC, et al
    Analysis of Factors Associated With In-hospital Mortality in Lung Cancer Chemotherapy Patients With Neutropenia.
    Clin Lung Cancer. 2017 Oct 28. pii: S1525-7304(17)30307.
    PubMed     Text format     Abstract available


  120. AGGARWAL C, Cohen RB, Yu E, Hwang WT, et al
    Etirinotecan Pegol (NKTR-102) in Third-line Treatment of Patients With Metastatic or Recurrent Non-Small-cell Lung Cancer: Results of a Phase II Study.
    Clin Lung Cancer. 2017 Oct 19. pii: S1525-7304(17)30281.
    PubMed     Text format     Abstract available


  121. INOUE T, Tamiya M, Tamiya A, Nakahama K, et al
    Analysis of Early Death in Japanese Patients With Advanced Non-small-cell Lung Cancer Treated With Nivolumab.
    Clin Lung Cancer. 2017 Oct 13. pii: S1525-7304(17)30274.
    PubMed     Text format     Abstract available


  122. CIULEANU T, Socinski MA, Obasaju C, Luft AV, et al
    Efficacy and Safety of Necitumumab Continuation Therapy in the Phase III SQUIRE Study of Patients With Stage IV Squamous Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2017 Oct 13. pii: S1525-7304(17)30278.
    PubMed     Text format     Abstract available


  123. KESARWALA AH, Lu DJ, Xanthopoulos E, Apisarnthanarax S, et al
    The Role of Advanced Imaging in Assessing Response to Definitive Chemoradiation Before Prophylactic Cranial Irradiation in Limited-Stage Small-Cell Lung Cancer.
    Clin Lung Cancer. 2017 Oct 12. pii: S1525-7304(17)30275.
    PubMed     Text format     Abstract available


    September 2017
  124. MA L, Ye W, Li Q, Wang B, et al
    Subjective Global Assessment (SGA) Score Could Be a Predictive Factor for Radiation Pneumonitis in Lung Cancer Patients With Normal Pulmonary Function Treated by Intensity-Modulated Radiation Therapy and Concurrent Chemotherapy.
    Clin Lung Cancer. 2017 Sep 19. pii: S1525-7304(17)30259.
    PubMed     Text format     Abstract available


  125. LANGER CJ, Paz-Ares LG, Wozniak AJ, Gridelli C, et al
    Safety Analyses of Pemetrexed-cisplatin and Pemetrexed Maintenance Therapies in Patients With Advanced Non-squamous NSCLC: Retrospective Analyses From 2 Phase III Studies.
    Clin Lung Cancer. 2017;18:489-496.
    PubMed     Text format     Abstract available


  126. REMON J, Menis J, Hasan B, Peric A, et al
    The APPLE Trial: Feasibility and Activity of AZD9291 (Osimertinib) Treatment on Positive PLasma T790M in EGFR-mutant NSCLC Patients. EORTC 1613.
    Clin Lung Cancer. 2017;18:583-588.
    PubMed     Text format     Abstract available


  127. TOYOKAWA G, Takada K, Okamoto T, Kozuma Y, et al
    High Frequency of Programmed Death-ligand 1 Expression in Emphysematous Bullae-associated Lung Adenocarcinomas.
    Clin Lung Cancer. 2017;18:504-511.
    PubMed     Text format     Abstract available


  128. GIRARD P, Caliandro R, Seguin-Givelet A, Lenoir S, et al
    Sensitivity of Cytology Specimens From Bronchial Aspirate or Washing During Bronchoscopy in the Diagnosis of Lung Malignancies: An Update.
    Clin Lung Cancer. 2017;18:512-518.
    PubMed     Text format     Abstract available


    August 2017
  129. AKTHAR AS, Koshy M, Ferguson MK, Murgu S, et al
    Effect of Endoscopic Bronchial Ultrasound on Outcomes for Stage I Non-Small-Cell Lung Cancer Patients Receiving Hypofractionated Radiotherapy.
    Clin Lung Cancer. 2017 Aug 31. pii: S1525-7304(17)30231.
    PubMed     Text format     Abstract available


  130. HALTHORE A, Goenka A, Sharma R, Knisely JPS, et al
    Prophylactic Cranial Irradiation for Resectable Small-Cell Lung Cancer.
    Clin Lung Cancer. 2017 Aug 26. pii: S1525-7304(17)30232.
    PubMed     Text format     Abstract available


  131. KIM E, Feldman R, Wistuba II
    Update on EGFR Mutational Testing and the Potential of Noninvasive Liquid Biopsy in Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Aug 12. pii: S1525-7304(17)30229.
    PubMed     Text format     Abstract available


  132. KAWAMURA T, Kenmotsu H, Omori S, Nakashima K, et al
    Clinical Factors Predicting Detection of T790M Mutation in Rebiopsy for EGFR-Mutant Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Aug 10. pii: S1525-7304(17)30210.
    PubMed     Text format     Abstract available


  133. BROSSEAU S, Gounant V, Naltet C, Theou-Anton N, et al
    Lazarus Syndrome With Crizotinib in a Non-Small Cell Lung Cancer Patient With ROS1 Rearrangement and Disseminated Intravascular Coagulation.
    Clin Lung Cancer. 2017 Aug 3. pii: S1525-7304(17)30211.
    PubMed     Text format    


    July 2017
  134. ALEXANDER M, Solomon B, Burbury K
    Thromboembolism in Anaplastic Lymphoma Kinase-Rearranged Non-Small Cell Lung Cancer.
    Clin Lung Cancer. 2017 Jul 22. pii: S1525-7304(17)30209.
    PubMed     Text format    


  135. ABUODEH Y, Naghavi AO, Echevarria M, DeMarco M, et al
    Quantitatively Excessive Normal Tissue Toxicity and Poor Target Coverage in Postoperative Lung Cancer Radiotherapy Meta-analysis.
    Clin Lung Cancer. 2017 Jul 8. pii: S1525-7304(17)30196.
    PubMed     Text format     Abstract available


  136. VERMA V, Simone CB 2nd
    Surgery Versus Conventional Radiation Therapy for T1-2 N0 M0 Small-cell Lung Cancer: A Fair Comparison?
    Clin Lung Cancer. 2017 Jul 6. pii: S1525-7304(17)30201.
    PubMed     Text format    


  137. YANG JC, Mok T, Han B, Orlando M, et al
    A Review of Regimens Combining Pemetrexed With an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in the Treatment of Advanced Nonsquamous Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2017 Jul 6. pii: S1525-7304(17)30200.
    PubMed     Text format     Abstract available


  138. TAKAMORI S, Toyokawa G, Takada K, Shoji F, et al
    Combination Therapy of Radiotherapy and Anti-PD-1/PD-L1 Treatment in Non-Small-cell Lung Cancer: A Mini-review.
    Clin Lung Cancer. 2017 Jul 6. pii: S1525-7304(17)30202.
    PubMed     Text format     Abstract available


  139. SONNICK MA, Oro F, Yan B, Desai A, et al
    Identifying the Optimal Radiation Dose in Locally Advanced Non-Small-cell Lung Cancer Treated With Definitive Radiotherapy Without Concurrent Chemotherapy.
    Clin Lung Cancer. 2017 Jul 6. pii: S1525-7304(17)30206.
    PubMed     Text format     Abstract available


  140. WEST HL, Moon J, Wozniak AJ, Mack P, et al
    Paired Phase II Studies of Erlotinib/Bevacizumab for Advanced Bronchioloalveolar Carcinoma or Never Smokers With Advanced Non-Small-cell Lung Cancer: SWOG S0635 and S0636 Trials.
    Clin Lung Cancer. 2017 Jul 6. pii: S1525-7304(17)30203.
    PubMed     Text format     Abstract available


    June 2017
  141. QIAO M, Jiang T, Ren S, Zhou C, et al
    Combination Strategies on the Basis of Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer: Where Do We Stand?
    Clin Lung Cancer. 2017 Jun 23. pii: S1525-7304(17)30178.
    PubMed     Text format     Abstract available


  142. ZUGAZAGOITIA J, Rueda D, Carrizo N, Enguita AB, et al
    Prospective Clinical Integration of an Amplicon-Based Next-Generation Sequencing Method to Select Advanced Non-Small-Cell Lung Cancer Patients for Genotype-Tailored Treatments.
    Clin Lung Cancer. 2017 Jun 23. pii: S1525-7304(17)30181.
    PubMed     Text format     Abstract available


  143. JIN F, Qu B, Fu Z, Zhang Y, et al
    Prognostic Value of Metabolic Parameters of Metastatic Lymph Nodes on 18F-FDG PET/CT in Patients With Limited-stage Small-cell Lung Cancer With Lymph Node Involvement.
    Clin Lung Cancer. 2017 Jun 22. pii: S1525-7304(17)30179.
    PubMed     Text format     Abstract available


  144. DUDANI S, Zhu X, Yokom DW, Yamada A, et al
    Radical Treatment of Stage II Non-small-cell Lung Cancer With Nonsurgical Approaches: A Multi-institution Report of Outcomes.
    Clin Lung Cancer. 2017 Jun 21. pii: S1525-7304(17)30180.
    PubMed     Text format     Abstract available


  145. OTSUBO K, Kishimoto J, Kenmotsu H, Minegishi Y, et al
    Treatment Rationale and Design for J-SONIC: A Randomized Study of Carboplatin Plus Nab-paclitaxel With or Without Nintedanib for Advanced Non-Small-cell Lung Cancer With Idiopathic Pulmonary Fibrosis.
    Clin Lung Cancer. 2017 Jun 20. pii: S1525-7304(17)30176.
    PubMed     Text format     Abstract available


  146. GAUT D, Sim MS, Yue Y, Wolf BR, et al
    Clinical Implications of the T790M Mutation in Disease Characteristics and Treatment Response in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC).
    Clin Lung Cancer. 2017 Jun 20. pii: S1525-7304(17)30177.
    PubMed     Text format     Abstract available


  147. NOMA D, Inamura K, Matsuura Y, Hirata Y, et al
    Prognostic Effect of Lymphovascular Invasion on TNM Staging in Stage I Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Jun 20. pii: S1525-7304(17)30174.
    PubMed     Text format     Abstract available


  148. KALMAN NS, Weiss E, Walker PR, Rosenman JG, et al
    Local Radiotherapy Intensification for Locally Advanced Non-small-cell Lung Cancer - A Call to Arms.
    Clin Lung Cancer. 2017 Jun 16. pii: S1525-7304(17)30173.
    PubMed     Text format     Abstract available


  149. MCGEE SF, Zhang T, Jonker H, Laurie SA, et al
    The Impact of Baseline Edmonton Symptom Assessment Scale Scores on Treatment and Survival in Patients With Advanced Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Jun 8. pii: S1525-7304(17)30167.
    PubMed     Text format     Abstract available


  150. UMAKOSHI H, Iwano S, Yokoi K, Ito S, et al
    FDG PET/CT Overcomes Discordance Between Clinical and Pathologic TNM Classification of Small-size Primary Lung Cancer: Influence on Postoperative Prognosis.
    Clin Lung Cancer. 2017 Jun 8. pii: S1525-7304(17)30170.
    PubMed     Text format     Abstract available


  151. YAMAMOTO N, Kenmotsu H, Yamanaka T, Nakamura S, et al
    Randomized Phase III Study of Cisplatin With Pemetrexed and Cisplatin With Vinorelbine for Completely Resected Nonsquamous Non-Small-Cell Lung Cancer: The JIPANG Study Protocol.
    Clin Lung Cancer. 2017 Jun 8. pii: S1525-7304(17)30169.
    PubMed     Text format     Abstract available


  152. PILOTTO S, Rossi A, Vavala T, Follador A, et al
    Outcomes of First-Generation EGFR-TKIs Against Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE-POSITIVE Study.
    Clin Lung Cancer. 2017 Jun 1. pii: S1525-7304(17)30165.
    PubMed     Text format     Abstract available


  153. RAZ DJ, Wu GX, Consunji M, Nelson RA, et al
    The Effect of Primary Care Physician Knowledge of Lung Cancer Screening Guidelines on Perceptions and Utilization of Low-Dose Computed Tomography.
    Clin Lung Cancer. 2017 Jun 1. pii: S1525-7304(17)30148.
    PubMed     Text format     Abstract available


  154. SADOYAMA S, Sekine A, Satoh H, Iwasawa T, et al
    Isolated Brain Metastases as the First Relapse After the Curative Surgical Resection in Non-Small-Cell Lung Cancer Patients With an EGFR Mutation.
    Clin Lung Cancer. 2017 Jun 1. pii: S1525-7304(17)30166.
    PubMed     Text format     Abstract available


    May 2017
  155. WOODARD GA, Wang SX, Kratz JR, Zoon-Besselink CT, et al
    Adjuvant Chemotherapy Guided by Molecular Profiling and Improved Outcomes in Early Stage, Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2017 May 31. pii: S1525-7304(17)30150.
    PubMed     Text format     Abstract available


  156. HAYASHI H, Chiba Y, Sakai K, Fujita T, et al
    A Randomized Phase II Study Comparing Nivolumab With Carboplatin-Pemetrexed for Patients With EGFR Mutation-Positive Nonsquamous Non-Small-Cell Lung Cancer Who Acquire Resistance to Tyrosine Kinase Inhibitors Not Due to a Secondary T790M Mutation: Rat
    Clin Lung Cancer. 2017 May 25. pii: S1525-7304(17)30147.
    PubMed     Text format     Abstract available


  157. WANG X, Yan S, Lv C, Wang Y, et al
    Impact of Omission of Intrapulmonary Lymph Node Retrieval on Outcome Evaluation of Lung Cancer Patients Without Lymph Node Metastasis: A Propensity Score Matching Analysis.
    Clin Lung Cancer. 2017 May 11. pii: S1525-7304(17)30136.
    PubMed     Text format     Abstract available


  158. FRELINGHUYSEN M, Fest J, Van der Voort Van Zyp NC, Van der Holt B, et al
    Consequences of Referral Time and Volume Doubling Time in Inoperable Patients With Early Stage Lung Cancer.
    Clin Lung Cancer. 2017 May 10. pii: S1525-7304(17)30137.
    PubMed     Text format     Abstract available


  159. SHIN JY, Yoon JK, Marwaha G
    External Validation of the New International Association for the Study of Lung Cancer Tumor, Node, and Metastasis 8th Edition Staging System and Updated T Descriptors in Determining Prognosis for Patients With Non-Small Cell Lung Cancer Patients With
    Clin Lung Cancer. 2017 May 10. pii: S1525-7304(17)30144.
    PubMed     Text format     Abstract available


  160. NAKAMICHI S, Horinouchi H, Asao T, Goto Y, et al
    Comparison of Radiotherapy and Chemoradiotherapy for Locoregional Recurrence of Non-small-cell Lung Cancer Developing After Surgery.
    Clin Lung Cancer. 2017 May 10. pii: S1525-7304(17)30140.
    PubMed     Text format     Abstract available


  161. YOKOTA H, Sato K, Okuda Y, Kobayashi H, et al
    Effects of Histamine 2-receptor Antagonists and Proton Pump Inhibitors on the Pharmacokinetics of Gefitinib in Patients With Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2017 May 10. pii: S1525-7304(17)30145.
    PubMed     Text format     Abstract available


  162. KATO R, Hayashi H, Chiba Y, Tanaka K, et al
    Prognostic Impact of Minimal Pericardial Effusion in Patients With Advanced Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2017 May 10. pii: S1525-7304(17)30146.
    PubMed     Text format     Abstract available


  163. LEONG TL, Christie M, Kranz S, Pham K, et al
    Evaluating the Genomic Yield of a Single Endobronchial Ultrasound-guided Transbronchial Needle Aspiration in Lung Cancer: Meeting the Challenge of Doing More With Less.
    Clin Lung Cancer. 2017 May 10. pii: S1525-7304(17)30141.
    PubMed     Text format     Abstract available


  164. GLISSON B, Besse B, Dols MC, Dubey S, et al
    A Randomized, Placebo-Controlled, Phase 1b/2 Study of Rilotumumab or Ganitumab in Combination With Platinum-Based Chemotherapy as First-Line Treatment for Extensive-Stage Small-Cell Lung Cancer.
    Clin Lung Cancer. 2017 May 10. pii: S1525-7304(17)30142.
    PubMed     Text format     Abstract available


  165. RAJUPET S, Doshi D, Wisnivesky JP, Lin JJ, et al
    Attitudes About Lung Cancer Screening: Primary Care Providers Versus Specialists.
    Clin Lung Cancer. 2017 May 10. pii: S1525-7304(17)30138.
    PubMed     Text format     Abstract available


  166. GARCIA S, Saltarski JM, Yan J, Xie XJ, et al
    Time and Effort Required for Tissue Acquisition and Submission in Lung Cancer Clinical Trials.
    Clin Lung Cancer. 2017 May 8. pii: S1525-7304(17)30132.
    PubMed     Text format     Abstract available


  167. WU AJ, Garay E, Foster A, Hsu M, et al
    Definitive Radiotherapy for Local Recurrence of NSCLC After Surgery.
    Clin Lung Cancer. 2017;18:e161-e168.
    PubMed     Text format     Abstract available


  168. SUN V, Raz DJ, Ruel N, Chang W, et al
    A Multimedia Self-management Intervention to Prepare Cancer Patients and Family Caregivers for Lung Surgery and Postoperative Recovery.
    Clin Lung Cancer. 2017;18:e151-e159.
    PubMed     Text format     Abstract available


    April 2017
  169. AHMED HZ, Liu Y, O'Connell K, Ahmed MZ, et al
    Guideline-concordant Care Improves Overall Survival for Locally Advanced Non-Small-cell Lung Carcinoma Patients: A National Cancer Database Analysis.
    Clin Lung Cancer. 2017 Apr 28. pii: S1525-7304(17)30114.
    PubMed     Text format     Abstract available


  170. GANTI AK, Hirsch FR, Wynes MW, Ravelo A, et al
    Access to Cancer Specialist Care and Treatment in Patients With Advanced Stage Lung Cancer.
    Clin Lung Cancer. 2017 Apr 26. pii: S1525-7304(17)30115.
    PubMed     Text format     Abstract available


  171. FENSKE DC, Price GL, Hess LM, John WJ, et al
    Systematic Review of Brain Metastases in Patients With Non-Small-Cell Lung Cancer in the United States, European Union, and Japan.
    Clin Lung Cancer. 2017 Apr 26. pii: S1525-7304(17)30116.
    PubMed     Text format     Abstract available


  172. CHO JH, Sorensen SF, Choi YL, Feng Y, et al
    Programmed Death Ligand 1 Expression in Paired Non-Small Cell Lung Cancer Tumor Samples.
    Clin Lung Cancer. 2017 Apr 24. pii: S1525-7304(17)30113.
    PubMed     Text format     Abstract available


  173. DAHELE M, Damhuis RA
    Relationship Between Tumor Location and Outcome in Patients With Early-Stage Lung Cancer.
    Clin Lung Cancer. 2017 Apr 23. pii: S1525-7304(17)30110.
    PubMed     Text format    


  174. GIULIANI J, Bonetti A
    Nivolumab in Second-Line Treatment for Advanced Non-Small-Cell Lung Cancer With Squamous-Cell Histology: A Perspective Based on Pharmacologic Costs.
    Clin Lung Cancer. 2017 Apr 23. pii: S1525-7304(17)30112.
    PubMed     Text format    


  175. GUTIERREZ ME, Choi K, Lanman RB, Licitra EJ, et al
    Genomic Profiling of Advanced Non-Small Cell Lung Cancer in Community Settings: Gaps and Opportunities.
    Clin Lung Cancer. 2017 Apr 13. pii: S1525-7304(17)30109.
    PubMed     Text format     Abstract available


  176. QIU B, Liang Y, Li Q, Liu G, et al
    Local Therapy for Oligoprogressive Disease in Patients With Advanced Stage Non-small-cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutation.
    Clin Lung Cancer. 2017 Apr 12. pii: S1525-7304(17)30107.
    PubMed     Text format     Abstract available


  177. CHEN K, Chen H, Yang F, Sui X, et al
    Validation of the Eighth Edition of the TNM Staging System for Lung Cancer in 2043 Surgically Treated Patients With Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Apr 12. pii: S1525-7304(17)30106.
    PubMed     Text format     Abstract available


    March 2017
  178. AHMED Z, Kujtan L, Kennedy KF, Davis JR, et al
    Disparities in the Management of Patients With Stage I Small Cell Lung Carcinoma (SCLC): A Surveillance, Epidemiology and End Results (SEER) Analysis.
    Clin Lung Cancer. 2017 Mar 30. pii: S1525-7304(17)30080.
    PubMed     Text format     Abstract available


  179. SAKAMOTO S, Yamada T, Terazaki Y, Yoshiyama K, et al
    Feasibility Study of Personalized Peptide Vaccination for Advanced Small Cell Lung Cancer.
    Clin Lung Cancer. 2017 Mar 24. pii: S1525-7304(17)30088.
    PubMed     Text format     Abstract available


  180. BATTISTI NML, Sehovic M, Extermann M
    Assessment of the External Validity of the National Comprehensive Cancer Network and European Society for Medical Oncology Guidelines for Non-Small-Cell Lung Cancer in a Population of Patients Aged 80 Years and Older.
    Clin Lung Cancer. 2017 Mar 21. pii: S1525-7304(17)30082.
    PubMed     Text format     Abstract available


  181. VERMA V, Rwigema JM, Adeberg S, Simone CB 2nd, et al
    Enrollment of Elderly Patients With Locally Advanced Non-Small Cell Lung Cancer in Multi-institutional Trials of Proton Beam Radiation Therapy.
    Clin Lung Cancer. 2017 Mar 16. pii: S1525-7304(17)30084.
    PubMed     Text format    


  182. CASSIDY RJ, Patel PR, Zhang X, Press RH, et al
    Stereotactic Body Radiotherapy for Early-stage Non-small-cell Lung Cancer in Patients 80 Years and Older: A Multi-center Analysis.
    Clin Lung Cancer. 2017 Mar 16. pii: S1525-7304(17)30083.
    PubMed     Text format     Abstract available


  183. JUAN O, Popat S
    Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer.
    Clin Lung Cancer. 2017 Mar 14. pii: S1525-7304(17)30079.
    PubMed     Text format     Abstract available


  184. DISTASIO M, Chen Y, Rangachari D, Costa DB, et al
    Molecular Testing Turnaround Time for Non-Small Cell Lung Cancer in Routine Clinical Practice Confirms Feasibility of CAP/IASLC/AMP Guideline Recommendations: A Single-center Analysis.
    Clin Lung Cancer. 2017 Mar 14. pii: S1525-7304(17)30078.
    PubMed     Text format     Abstract available


  185. YONEDA KY, Scranton JR, Cadogan MA, Tassell V, et al
    Interstitial Lung Disease Associated With Crizotinib in Patients With Advanced Non-Small Cell Lung Cancer: Independent Review of Four PROFILE Trials.
    Clin Lung Cancer. 2017 Mar 14. pii: S1525-7304(17)30081.
    PubMed     Text format     Abstract available


  186. SCHULKES KJ, Souwer ET, van Elden LJ, Codrington H, et al
    Prognostic Value of Geriatric 8 and Identification of Seniors at Risk for Hospitalized Patients Screening Tools for Patients With Lung Cancer.
    Clin Lung Cancer. 2017 Mar 2. pii: S1525-7304(17)30049.
    PubMed     Text format     Abstract available


  187. TAKADA K, Toyokawa G, Okamoto T, Shimokawa M, et al
    A Comprehensive Analysis of Programmed Cell Death Ligand-1 Expression With the Clone SP142 Antibody in Non-Small-Cell Lung Cancer Patients.
    Clin Lung Cancer. 2017 Mar 2. pii: S1525-7304(17)30047.
    PubMed     Text format     Abstract available


  188. LI WN, Wang DF, Zhao YB, Qiu XS, et al
    Comparative Analysis for Diagnostic Yield of Small Cell Lung Cancer by Cytology and Histology During the Same Bronchoscopic Procedure.
    Clin Lung Cancer. 2017 Mar 2. pii: S1525-7304(17)30052.
    PubMed     Text format     Abstract available


  189. SPIGEL DR, Luft A, Depenbrock H, Ramlau R, et al
    An Open-Label, Randomized, Controlled Phase II Study of Paclitaxel-Carboplatin Chemotherapy With Necitumumab Versus Paclitaxel-Carboplatin Alone in First-Line Treatment of Patients With Stage IV Squamous Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2017 Mar 2. pii: S1525-7304(17)30045.
    PubMed     Text format     Abstract available


  190. MORRISON EJ, Novotny PJ, Sloan JA, Yang P, et al
    Emotional Problems, Quality of Life, and Symptom Burden in Patients With Lung Cancer.
    Clin Lung Cancer. 2017 Mar 2. pii: S1525-7304(17)30051.
    PubMed     Text format     Abstract available


  191. WU GX, Nelson RA, Kim JY, Raz DJ, et al
    Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
    Clin Lung Cancer. 2017 Mar 2. pii: S1525-7304(17)30050.
    PubMed     Text format     Abstract available


  192. SONG Z, Wang X, Zheng Y, Su H, et al
    MET Gene Amplification and Overexpression in Chinese Non-Small-Cell Lung Cancer Patients Without EGFR Mutations.
    Clin Lung Cancer. 2017;18:213-219.
    PubMed     Text format     Abstract available


  193. GUILBAULT C, Garant A, Faria S, Owen S, et al
    Long-term Outcomes of Induction Carboplatin and Gemcitabine Followed by Concurrent Radiotherapy With Low-dose Paclitaxel and Gemcitabine for Stage III Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Mar 1. pii: S1525-7304(17)30046.
    PubMed     Text format     Abstract available


  194. MORIMOTO M, Okishio K, Akira M, Omachi N, et al
    Duration of Twice-Daily Thoracic Radiotherapy and Time From the Start of Any Treatment to the End of Chest Irradiation as Significant Predictors of Outcomes in Limited-Disease Small-Cell Lung Cancer.
    Clin Lung Cancer. 2017;18:e117-e127.
    PubMed     Text format     Abstract available


  195. ZHAO R, Kong W, Shang J, Zhe H, et al
    Hippocampal-Sparing Whole-Brain Radiotherapy for Lung Cancer.
    Clin Lung Cancer. 2017;18:127-131.
    PubMed     Text format     Abstract available


    February 2017
  196. ELLIS PM, Vella ET, Ung YC
    Immune Checkpoint Inhibitors for Patients With Advanced Non-Small-Cell Lung Cancer: A Systematic Review.
    Clin Lung Cancer. 2017 Feb 16. pii: S1525-7304(17)30043.
    PubMed     Text format     Abstract available


  197. QIN A, Street L, Cease K, Viglianti BL, et al
    Clinical Determinants of Durable Clinical Benefit of Pembrolizumab in Veterans With Advanced Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2017 Feb 9. pii: S1525-7304(17)30041.
    PubMed     Text format     Abstract available


    January 2017
  198. SOO RA, Kubo A, Ando M, Kawaguchi T, et al
    Association Between Environmental Tobacco Smoke Exposure and the Occurrence of EGFR Mutations and ALK Rearrangements in Never-smokers With Non-Small-cell Lung Cancer: Analyses From a Prospective Multinational ETS Registry.
    Clin Lung Cancer. 2017 Jan 19. pii: S1525-7304(17)30020.
    PubMed     Text format     Abstract available


  199. SOCINSKI MA, Kaye FJ, Spigel DR, Kudrik FJ, et al
    Phase 1/2 Study of the CD56-Targeting Antibody-Drug Conjugate Lorvotuzumab Mertansine (IMGN901) in Combination With Carboplatin/Etoposide in Small-Cell Lung Cancer Patients With Extensive-Stage Disease.
    Clin Lung Cancer. 2017;18:68-76.
    PubMed     Text format     Abstract available


  200. YONESHIMA Y, Morita S, Ando M, Miura S, et al
    Treatment Rationale and Design for J-AXEL: A Randomized Phase 3 Study Comparing Nab-Paclitaxel With Docetaxel in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2017;18:100-103.
    PubMed     Text format     Abstract available


    October 2016
  201. ZHANG Y, Zhang Z, Huang X, Kang S, et al
    Therapeutic Efficacy Comparison of 5 Major EGFR-TKIs in Advanced EGFR-positive Non-Small-cell Lung Cancer: A Network Meta-analysis Based on Head-to-Head Trials.
    Clin Lung Cancer. 2016 Oct 27. pii: S1525-7304(16)30231.
    PubMed     Text format     Abstract available


    May 2016
  202. PLANCHARD D, Yokoi T, McCleod MJ, Fischer JR, et al
    A Phase III Study of Durvalumab (MEDI4736) With or Without Tremelimumab for Previously Treated Patients With Advanced NSCLC: Rationale and Protocol Design of the ARCTIC Study.
    Clin Lung Cancer. 2016;17:232-236.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: